chr11-47342914-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM1BP4
The NM_000256.3(MYBPC3):c.1373G>A(p.Arg458His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000434 in 1,611,840 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000256.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYBPC3 | ENST00000545968.6 | c.1373G>A | p.Arg458His | missense_variant | Exon 16 of 35 | 5 | NM_000256.3 | ENSP00000442795.1 | ||
MYBPC3 | ENST00000399249.6 | c.1373G>A | p.Arg458His | missense_variant | Exon 15 of 34 | 5 | ENSP00000382193.2 | |||
MYBPC3 | ENST00000544791.1 | n.1373G>A | non_coding_transcript_exon_variant | Exon 16 of 27 | 5 | ENSP00000444259.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152238Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000490 AC: 12AN: 245044Hom.: 0 AF XY: 0.0000601 AC XY: 8AN XY: 133004
GnomAD4 exome AF: 0.0000466 AC: 68AN: 1459602Hom.: 0 Cov.: 31 AF XY: 0.0000496 AC XY: 36AN XY: 725942
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152238Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74378
ClinVar
Submissions by phenotype
Cardiomyopathy Uncertain:2
This missense variant replaces arginine with histidine at codon 458 of the MYBPC3 protein. Computational prediction tools indicate that this variant has a neutral impact on protein structure and function. To our knowledge, functional studies have not been reported for this variant. This variant has been reported in two individuals affected with hypertrophic cardiomyopathy (PMID: 15519027, 21302287) and in two individuals affected with dilated cardiomyopathy (PMID: 24119082, 27532257). This variant has been identified in 13/276446 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
- -
not provided Uncertain:2
The p.Arg458His variant in MYBPC3 has been identified in 1 individual with HCM and was absent from 200 Black and 200 Caucasian chromosomes (Van Driest 2004). This variant has been identified in 1/8322 European American chromosomes and 1/4076 African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/), though these could represent presymptomatic individuals. Low frequency in the general population supports pathogenicity but is not sufficient to rule out a benign role. Our laboratory has detected this variant in 2 individuals with DCM (1 infant, 1 adult). The infant’s unaffected father also carried the variant, raising suspicion whether it was solely responsible for the infant’s DCM. Additional evidence also supports a milder or benign role. Arginine at position 458 is not conserved evolution and several species (chicken, zebra finch, frog) carry the variant amino acid, suggesting that the change may be tolerated. The change was also predicted to be benign using a computational tool, which was validated by our laboratory using a set of cardiomyopathy variants with well-established clinical significance. This tool's benign interpretation is estimated to be correct 89% of the time (Jordan 2011). In summary, this variant is less likely disease causing in isolation but additional information is needed to establish its role with confidence. -
The MYBPC3 p.Arg458His variant was identified in the literature in two individuals with hypertrophic cardiomyopathy and one family with dilated cardiomyopathy; the variant was not identified in 200 control individuals (Driest_2004_PMID:15519027, Roncarati_2011_PMID:21302287, Merlo_2013_PMID:2411908). The variant was identified in dbSNP (ID: rs374255707) and ClinVar (classified as uncertain significance by CHEO Genetics Diagnostic Laboratory Children's Hospital of Eastern Ontario, Laboratory for Molecular Medicine and CSER _CC_NCGL, University of Washington). The variant was identified in control databases in 13 of 276446 chromosomes at a frequency of 0.00004703 (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: East Asian in 2 of 19418 chromosomes (freq: 0.000103), European (non-Finnish) in 8 of 126152 chromosomes (freq: 0.000063), Latino in 2 of 34956 chromosomes (freq: 0.000057) and South Asian in 1 of 30096 chromosomes (freq: 0.000033), but was not observed in the African, Ashkenazi Jewish, European (Finnish), or Other populations. The p.Arg458 residue is conserved in mammals but not in more distantly related organisms however computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. -
Hypertrophic cardiomyopathy Uncertain:2
This missense variant replaces arginine with histidine at codon 458 of the MYBPC3 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in individuals affected with hypertrophic cardiomyopathy (PMID: 15519027, 21302287) and in individuals affected with dilated cardiomyopathy (PMID: 24119082, 27532257). This variant has been identified in 13/276446 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 458 of the MYBPC3 protein (p.Arg458His). This variant is present in population databases (rs374255707, gnomAD 0.01%). This missense change has been observed in individuals with dilated cardiomyopathy or hypertrophic cardiomyopathy (PMID: 15519027, 21302287, 24119082, 27532257). ClinVar contains an entry for this variant (Variation ID: 42527). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Hypertrophic cardiomyopathy 4;C3715165:Left ventricular noncompaction 10 Uncertain:1
- -
Primary familial hypertrophic cardiomyopathy Uncertain:1
- -
Cardiovascular phenotype Uncertain:1
The p.R458H variant (also known as c.1373G>A), located in coding exon 16 of the MYBPC3 gene, results from a G to A substitution at nucleotide position 1373. The arginine at codon 458 is replaced by histidine, an amino acid with highly similar properties. This alteration has been reported in subjects with hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM) (Van Driest SL et al. J. Am. Coll. Cardiol., 2004 Nov;44:1903-10; Merlo M et al. Clin Transl Sci, 2013 Dec;6:424-8; Roncarati R et al. J. Cell. Physiol., 2011 Nov;226:2894-900; Pugh TJ et al. Genet. Med., 2014 Aug;16:601-8; Walsh R et al. Genet. Med., 2017 02;19:192-203). This alteration has also been seen in exome cohorts, but cardiovascular history was not provided (Andreasen C et al. Eur J Hum Genet. 2013;21(9):918-28; Dorschner MO et al. Am J Hum Genet. 2013;93(4):631-40; Amendola LM et al. Genome Res. 2015;25(3):305-15). This amino acid position is not well conserved in available vertebrate species, and histidine is the reference amino acid in other vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at